Since the symptoms of psoriasis may be changed by treatment with selective serotonin reuptake inhibitors (SSRIs), the expression of serotonin (5-HT) and its transporter protein (SERT) in the skin of patients with psoriasis were examined employing a biotinylated-streptavidine procedure. In biopsies of such skin staining for 5-HT was limited to platelets; the expression of SERT in the keratinocytes of involved regions was redistributed; the numbers of SERT-positive dendritic or round mononuclear cells in the epidermis of involved psoriatic skin were higher than in normal healthy control skin; and the dermis of the involved skin contained higher numbers of round inXammatory cells immunostained for SERT than either non-involved psoriatic skin or normal skin. Double-immunostaining indicated that the skin cells expressing SERT also expressed CD1a, CD3 or tryptase. In addition, SERT immunostaining was co localized with caspase-3, a key regulator of apoptosis, but not with TUNEL staining. The present Wndings indicate that SERT might play a role in regulating apoptosis in inXammatory cells associated with psoriasis, in which case this protein might constitute a valuable therapeutic target.
Introduction
Psoriasis, which is characterized by enhanced proliferation and altered diVerentiation of epithelial cells, may occur or worsen in connection with stress or mood disorders [5, 18] , as well as following treatment with the selective serotonin reuptake inhibitors (SSRIs), paroxetine [16] and Xuoxetine [6] . However, at the same time, paroxetine has been reported to alleviate the symptoms of patients suVering from psoriasis and depression [1] .
The interactive communication that occurs between the neuroendocrine and immune systems may be mediated in part by serotonin (5-hydroxytryptamin; 5-HT), which acts as an important neurotransmitter and is present in high concentrations at the sites of inXammation. The duration and magnitude of the responses to 5-HT are mediated by the serotonin transporter protein (SERT), a protein with 12-transmembrane domains, which mediates the high-aYnity reuptake essential for the synaptic clearance of 5-HT.
5-HT, via its receptors, is involved in the physiological functions of the skin [19, 20] . There are indications that 5-HT plays a role in connection with diVerent types of inXammation of the skin, including psoriasis [14, 22] . For example, Huang et al. [7] demonstrated by using immunohistochemistry that 5-HT was present in the epidermis of preferably progressive psoriasis in contrast to normal skin, suggesting a role for 5-HT in the pathogenesis of this disease. Moreover, in our previous study we detected the expression of 5-HT receptors in connection with psoriasis [13] , opening the possibility that receptor-speciWc serotonergic drugs might have a beneWcial therapeutic eVect in psoriasis.
In the present investigation, we characterized the expression of 5-HT and SERT in both the involved and uninvolved skin of patients with psoriasis as well as in normal healthy human skin, employing immunohistochemical analysis. Since the SERT protein has been proposed to play a role in connection with apoptosis of neuronal cells in the brain [17] , we also used TUNEL staining and looked for a e Negative control with omitted primary antibody in the involved psoriatic skin. Scale bars 50 m possible co-localization of SERT with caspase-3, a major regulator of apoptosis.
Materials and methods

Biopsy specimens
Biopsies of involved and non-involved skin were taken from the backs of ten patients with a plaque type of psoriasis who were otherwise healthy [six men and four women with a mean age of 48 years (range 24-85 years)]. With the exception of emollients, all treatment of the disease was avoided for a period of 2 weeks prior to taking these biopsies. Biopsies were also taken from ten subjects free from inXammatory dermatoses [Wve men and Wve women with a mean age of 57 years (range 22-77 years)]. These studies were pre-approved by the local ethical committee.
Processing of the specimens
The skin specimens were Wrst immersed in phosphatebuVered 4% formaldehyde containing 0.17% picric acid for 1 h and thereafter rinsed in 0.1 M Sörensen's phosphatebuVered saline (PBS) supplemented with 10% sucrose for at least 24 h. The samples were then frozen rapidly on dry ice and stored at ¡70°C until further processing. While still frozen, the biopsy material was placed in a tissue holder, embedded in Tissue Tek OCT Compound (Sakuro Finetek, Zoeterwoude, The Netherlands), sliced into 14-m thick sections with a Microm HM500 cryostat (Heidelberg, Germany) and Wnally thawed onto Super Frost slides for immunohistochemical staining with a biotinylated streptavidine procedure.
Immunohistochemical analysis
Sections prepared as described above were incubated Wrst with 10% normal goat serum (S-100, Vector, Burlinghame, CA, USA) for 40 min and thereafter with a polyclonal antibody directed against 5-HT (20080, dilution 1:10,000; Diasorin, Millwater, USA), or alternatively, with 10% normal horse serum (S-2000, Vector), followed by a mouse monoclonal antibody toward SERT, directed against a peptide consisting of amino acid residues 51-66 coupled to keyhole limpet hemocyanin (KLH) through an additional N-terminal cysteine residue (ST51-1, diluted 1:10,000; MabTechnologies, Stone Mountain, GA, USA). Thereafter, incubation with streptavidine-biotin-labeled anti-rabbit (BA-1000) or anti-mouse (BA-2000) IgG (both in dilution 1:200; Vector) as the secondary antibodies was performed, followed by treatment with the Xuorochrome Cy2-labelled streptavidine (PA42001, 1:2,000; Amersham Biosciences, Uppsala, Sweden). All antibody solutions were diluted in PBS containing 1% bovine serum albumine (BSA) (A9418, Sigma-Aldrich, Stockholm, Sweden) prior to use.
Control staining with unspeciWc mouse IgG of the same isotype (X0931, Dako, Glostrup, Denmark) and in the same ¡6 mol/L, eliminated the immunostaining. Moreover, when the primary antibodies were omitted, no staining occurred (Figs. 1b, 2e) .
To perform double-staining designed to characterize the phenotype of the inXammatory cells expressing SERT, the biopsy sections were Wrst incubated with the antibody against SERT, followed by the streptavidine-biotin-labeled secondary antibody overnight and then Texas Red (SA-5006, dilution1:2,000; Vector). The next day, each section was incubated with rabbit polyclonal antibodies toward tryptase (diluted 1:1,000; a kind gift from I. Harvima, Tampere, Finland) or CD3 (NCL-CD3p, dilution 1:50; Novocastra Lab, Newcastle, UK) or a mouse monoclonal antibody speciWc for CD1a (555806, dilution 1:320; Becton-Dickinson, San Jose, CA, USA), followed in the case of tryptase and CD3 by a Xuorescein isothiocyanate (FITC)-conjugated swine-antirabbit antibody (F0205, dilution 1:40; Dako), and for CD1a, a donkey anti-mouse FITC-conjugated antibody (F0261, 1:150; Jackson ImmunoResearch, West Grove, PA, USA). Similarly, SERT-stained cells were double-stained for caspase-3 employing a polyclonal rabbit antibody against this protein (AF835, dilution 1:100; R&D System, Minneapolis, MN, USA), followed by the FITC-conjugated swine anti-rabbit IgG antibody in the same way. 
Microscopic quantitation and statistical analyses
All of the sections were cover slipped with glycerol/gelatine (Merck, Darmstadt, Germany) prior to examination in an immunoXuorescence Zeiss Axioskop microscope. The numbers of SERT-labeled cells in the epidermis and papillary dermis were counted by the same observer (KT). For each biopsy, the mean number of cells in four diVerent sections was determined and these values used to calculate the mean § SD value for all of the specimens in each group. In the case of double-staining for caspase-3 and SERT, the mean § SD for seven diVerent biopsies was calculated in the same manner.
The Mann-Whitney U test was utilized to compare the total numbers of labelled cells in the epidermis and dermis, of involved and non-involved skin, from the patients with psoriasis and normal (control) skin, with a P value of <0.05 being considered as statistically signiWcant. 
Results
Immunohistochemical staining revealed the presence of 5-HT in the platelets of the involved psoriatic skin (Fig. 1a) . There was also a focal expression of 5-HT in keratinocytes in the epidermis of two out of ten biopsies of the involved psoriatic skin, where you could see a high grade of inXammation and acanthosis, and a more diVuse staining in one out of ten of the biopsies of the non-involved psoriatic skin. In the control skin, only one out of ten biopsies showed a weak staining in the apical part of the epidermis (not shown).
A focal or basal epidermal expression of SERT could be seen in 7/10 biopsies of the involved psoriatic skin, whereas 5/10 of the patients showed an expression for SERT in the apical epidermis of the non-involved skin (Fig. 2a, b) . In the control skin, a weaker staining than the non-involved skin could also been seen in the apical part of the epidermis in 8/10 of the patients (Fig. 2c) . Moreover, intense SERT immunoreactivity was found in the epidermal adnexal structures, including hair follicles, irrespective of skin inXammation (Fig. 2d) .
The most important observation was the occurrence of SERT-positive mononuclear inXammatory cells in the epidermis and dermis. The numbers of epidermal SERT-positive dendritic or round cells (Fig. 3a) in the involved psoriatic skin (14 § 9 cells per section) was signiWcantly higher than in the normal control skin (5 § 7 cells per section; P < 0.05), but not signiWcantly diVerent than in the Fig. 9 Co-localization of SERT with caspase-3 in the involved psoriatic skin. a SERT (Texas Red), b caspase-3 (FITC), c SERT + caspase-3. Scale bars 50 m non-involved psoriatic skin (9 § 10 cells per section; Fig. 4 ). There were also signiWcantly larger numbers of SERT-positive round mononuclear cells in the papillary dermis of the involved skin ( Fig. 3b ; 121 § 47 cells per section) than in the normal control and non-involved skin (58 § 12 and 82 § 23 cells per section; P < 0.01), as well as in the non-involved compared to the normal control skin (P < 0.05; Fig. 5 ). In addition, double-staining revealed that cells staining positively for SERT also could express CD1a, CD3 or tryptase (Fig. 6a-c, shown for CD3; Fig. 7a -c, shown for CD1a; and Fig. 8a-c, shown for tryptase) . Of the CD3-positive cells 32 § 2% and for CD1a positive cells 10 § 3% also expressed SERT. Of the tryptase-positive cells only 2 § 2% were stained for SERT. Furthermore, 68 § 21% of the SERT-positive cells in the papillary dermis, but only a few of these cells in the epidermis, also stained for caspase-3 (Fig. 9) . TUNEL staining showed a signal only in the apical epidermis (stratum corneum) of the involved skin (Fig. 10) .
Discussion
The present investigation documents elevated numbers of dendritic or round mononuclear cells that express SERT in the epidermis and papillary dermis of psoriatic skin. These results are in agreement with our earlier Wndings in other inXammatory skin diseases, allergic contact eczema [4] and atopic eczema [11] .
Dendritic cells have been reported to express SERT at a level that is regulated by their state of maturation. Furthermore, 5-HT is transmitted between lymphocytes and dendritic cells [15] .
The level of apoptosis among neuronal cells in transgenic mice, which do not express functional SERT is attenuated [17] . The co localization of immunostaining for SERT with the expression of caspase-3, and the lack of such co localization with TUNEL staining observed here, might indicate that the immune cells of the skin that enter into apoptosis may express SERT. If this is the case, this apoptotic process might possibly be inXuenced by modulators of SERT, which may be of clinical relevance in connection with the treatment of psoriatic patients with antidepressants. Further studies will also focus on characterizing the phenotypes of inXammatory cells expressing SERT.
In addition, we found a modiWed epithelial SERT staining in psoriatic skin compared to normal healthy skin. The results of the studies on intestinal inXammation in experimental animals and humans regarding mucosal expression of SERT have been inconsistent. For instance, the levels of SERT mRNA have been reported to be elevated in the small intestine of patients with irritable bower syndrome (IBS) [8] , reduced in rectal biopsies of patients with ulcerative colitis and IBS [3] , and in guinea pig colitis [10] , and normal in rectal and sigmoidal mucosal biopsies of patients with IBS [2] . This modiWed epithelial expression indicates that SERT may have a direct role also for the epithelial proliferation and diVerentiation in psoriasis.
The increase in SERT protein could be either in response to inXammation or an initial event leading to inXammation. It has been shown that SERT synthesis may be stimulated by important cytokines for psoriasis pathogenesis, such as IFN- [23] .
In contrast to the Wndings with SERT, 5-HT with a few exceptions could be seen to be expressed only in platelets. The discrepancy between our Wndings with 5-HT and the Wndings by Huang et al. [7] , showing epidermal 5-HT expression, might be explained by diVerent immunohistochemical methods employed, in addition to a diVerent disease activity in the respective patient groups.
Previously, oral administration of the tricyclic antidepressant imipramine or bupropion, a weak inhibitor of the uptake of norepinephrine and dopamine in the brain, has been reported to ameliorate the symptoms of psoriasis [12] , possibly via inhibition of TNF-. Moreover, SSRI therapy of major depressive disorders may reduce the levels of proinXammatory markers [9] . On the other hand, the onset of guttate psoriasis could be precipitated by Ecstasy 
